Exploristics have implemented tools that use existing clinical data to identify subgroups of patients with improved response to treatment. These tools can be applied at a study or portfolio level and enable an informed and pragmatic approach to development decisions.

To date, these tools have been used as a precursor to Pharmacogenetics studies but can be applied to any subgroup analyses. For more information on this service and other services, view our case study, visit our website or contact us at info@exploristics.com.